OPRX vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum? – July 16, 2025
Key Takeaways OPRX Q1 revenues rose 11% YoY to $21.9M, with 80% FY25 revenues already under contract. GDRX posted 2.6%...
Revenue
WELL Health Technologies (TSX:WELL) Sees Revenue Surge With 2025 Guidance Reaching A$1.40 Billion
WELL Health Technologies recently provided robust earnings and revenue guidance, projecting revenue between CAD 1.40 billion and CAD 1.45 billion...
Haoxi Health Technology Limited Announces Preliminary Unaudited FY24 Financial Results with projected 72% Revenue Growth
Haoxi Health Technology (HAO), an online marketing solution provider in Beijing, China, has announced preliminary...
